Found 6 matching trials
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
PHASE2This is a study to evaluate the safety and efficacy of EIK1001 administered...
Location
Southern Cancer Center, P.C.
A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC
PHASE2This study is for patients with advanced/metastatic non-small cells lung ca...
Status
Active Not Recruiting
Location
Southern Cancer Care
Clinical Study of BDB018: Monotherapy and in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors
PHASE1A Phase 1 Open-label Dose Escalation Trial of BDB018 in Monotherapy and in ...
Location
Florida Cancer Specialists
BDB001-101: Clinical Study of BDB001 as a Mono-therapy or in Combination With Pembrolizumab
PHASE1Phase 1 Open-Label Dose Escalation Study of BDB001 as a Single Agent and in...
Location
Florida Cancer Specialists
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
PHASE2The study is for patients with advanced melanoma who are eligible for stand...
Location
Ironwood Cancer & Research Centers
BDB001-102: Open Label Dose Escalation of BDB001 in Combination w Atezolizumab
PHASE1A Phase 1 Open-label Dose Escalation Study of BDB001 in Combination with At...